Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
11.83
-0.51 (-4.13%)
At close: Mar 20, 2026, 4:00 PM EDT
11.70
-0.13 (-1.10%)
After-hours: Mar 20, 2026, 7:26 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines
1.75B1.69B1.47B1.43B1.37B
Affordable Medicines Growth
3.58%14.53%2.75%4.81%1.72%
Avkare
744.73M662.95M531.75M406.11M349.01M
Avkare Growth
12.34%24.67%30.94%16.36%18.81%
Specialty
528.51M445.75M390.46M374.12M378.32M
Specialty Growth
18.57%14.16%4.37%-1.11%6.40%
Total
3.02B2.79B2.39B2.21B2.09B
Total Growth
8.05%16.73%8.20%5.67%5.08%
Source: S&P Global Market Intelligence.